You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nanobody

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, Colorectal Cancer Trial in Beijing (18F-FDG)

Recruiting
  • Lung Cancer
  • Colorectal Cancer
  • Beijing, China
    Beijing Cancer Hospital
Mar 27, 2023

Solid Tumor Trial in Beijing (18F-FDG)

Recruiting
  • Solid Tumor
  • Beijing, Beijing, China
    Beijing cancer hospital
Jun 23, 2022

Lung Cancer, Melanoma, PD-L1 Trial in Beijing (68Ga-THP-APN09)

Recruiting
  • Lung Cancer
  • +3 more
  • 68Ga-THP-APN09
  • Beijing, Beijing, China
    Beijing cancer hospital
Dec 12, 2021

Hidradenitis Suppurativa Trial (SAR442970, Placebo)

Not yet recruiting
  • Hidradenitis Suppurativa
  • (no location specified)
Apr 28, 2023

Osteoarthritis, Knee Trial in Copenhagen NV (M6495, Placebo)

Completed
  • Osteoarthritis, Knee
  • Copenhagen NV, Denmark
    DanTrials ApS
Jan 22, 2020

Hidradenitis Suppurativa Trial in Worldwide (Sonelokimab (M1095), Adalimumab, Placebo)

Recruiting
  • Hidradenitis Suppurativa
  • Sonelokimab (M1095)
  • +2 more
  • Fountain Valley, California
  • +56 more
Feb 1, 2023

Healthy Volunteers Trial in Beijing (RC1416(SAD), Placebo(SAD))

Recruiting
  • Healthy Volunteers
  • Beijing, Beijing, China
    China-japan Friendship Hospital
Sep 27, 2023

Healthy Trial in Copenhagen (M6495, Placebo)

Completed
  • Healthy
  • Copenhagen, Denmark
    DanTrials ApS c/o Bispebjerg Hospital
Apr 30, 2019

B-Cell Lymphoma Stage I, Refractory, Relapsed Trial in Zhengzhou (CD19/CD20 bispecific CAR-T cells)

Unknown status
  • B-Cell Lymphoma Stage I
  • +2 more
  • CD19/CD20 bispecific CAR-T cells
  • Zhengzhou, Henan, China
  • +1 more
Mar 19, 2019

Cancer Trial in Beijing (99mTc-MIRC208)

Recruiting
  • Cancer
  • Beijing, Beijing, China
    Hua Zhu
Jul 18, 2022

Acquired Thrombotic Thrombocytopenic Purpura Trial in Worldwide (Caplacizumab, Placebo)

Completed
Has Results
  • Acquired Thrombotic Thrombocytopenic Purpura
  • Caplacizumab
  • Placebo
  • Los Angeles, California
  • +50 more
May 6, 2019

Breast Tumor, Breast Carcinoma, Receptor, ErbB-2 Trial in Brussels (68GaNOTA-Anti-HER2 VHH1)

Recruiting
  • Breast Neoplasm
  • +2 more
  • 68GaNOTA-Anti-HER2 VHH1
  • Brussels, Belgium
    Uz Brussel
Mar 4, 2022

Arthritis, Psoriatic Trial in Bulgaria, Poland, United States (Sonelokimab, Placebo, Adalimumab)

Recruiting
  • Arthritis, Psoriatic
  • Rancho Mirage, California
  • +10 more
Jan 24, 2023

Breast Carcinoma, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Chicago

Not yet recruiting
  • Breast Carcinoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • Chicago, Illinois
    Northwestern University
Nov 14, 2023

Relapsed/Refractory Myeloma Trial in Zhengzhou (BCMA nanobody CAR-T cells)

Unknown status
  • Relapsed/Refractory Myeloma
  • BCMA nanobody CAR-T cells
  • Zhengzhou, Henan, China
    Cancer Hospital Affiliate to Zhengzhou University & Henan Cancer
Sep 7, 2018

Rheumatoid Arthritis Trial in Czechia, Hungary, Poland (ALX-0061, Placebo)

Completed
  • Rheumatoid Arthritis
  • ALX-0061
  • Placebo
  • Prague, Czechia
  • +6 more
Jan 3, 2019

Breast Cancer Trial in Shanghai (Injection of 99mTc-NM-02)

Unknown status
  • Breast Cancer
  • Injection of 99mTc-NM-02
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Dec 6, 2020

Caplacizumab in Treatment of Acquired Thrombotic

Not yet recruiting
  • Acquired Thrombotic Thrombocytopenic Purpura
  • Cologne, Germany
    University Hospital of Cologne
May 25, 2023

Breast Cancer, Radiotoxicity Trial in Shanghai (Injection of 99mTc-NM-02, Injection of 188Re-NM-02)

Unknown status
  • Breast Cancer
  • Radiotoxicity
  • Injection of 99mTc-NM-02
  • Injection of 188Re-NM-02
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Dec 14, 2020

Psoriasis Trial in Worldwide (M1095 (Sonelokimab), Placebo, Secukinumab)

Completed
Has Results
  • Psoriasis
  • M1095 (Sonelokimab)
  • +2 more
  • Birmingham, Alabama
  • +59 more
Aug 2, 2021

Psoriasis Trial in Darmstadt (MSB0010841, Placebo)

Completed
Has Results
  • Psoriasis
  • Darmstadt, Germany
    Please contact the Merck KGaA Communication Center
Nov 28, 2016

RSV Infection Trial in Groningen (ALX-0171, Placebo)

Completed
  • RSV Infection
  • ALX-0171
  • Placebo
  • Groningen, Netherlands
    (unnamed)
Jul 12, 2018

Healthy Volunteers Trial in Groningen (ALX-0651, Placebo)

Terminated
  • Healthy Volunteers
  • ALX-0651
  • Placebo
  • Groningen, Netherlands
    (unnamed)
Apr 16, 2012